Coming soon: Comparative effectiveness research for biotech
The stimulus package includes $1.1 billion in funding for so-called comparative-effectiveness research aimed at determining which treatment works best for a given medical condition. Now the NIH has published a list of high-priority projects it wants to fund, providing a clearer picture of just how that money may be spent. The list suggests scrutiny for some of the best-selling drugs for heart conditions and asthma, among others.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- 3 Traits Personality Assessments Can't Reveal
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Carondelet to Pay $35M to Settle Fraud Allegations
- CHS Hacked, 4.5M Patient Records Compromised